Home
by admin

Metasphere Labs Announces LIFE Offering to Raise Up to $1 Million

Vancouver, British Columbia — March 12, 2026 — Leads & Copy — Metasphere Labs Inc. has announced a listed issuer financing exemption offering (LIFE Offering) for a minimum of 2,272,727 and a maximum of 9,090,909 common shares at a price of $0.11 per share.

The company (CSE:LABZ ) (OTC: LABZF) (FRA: H1N) is aiming for minimum gross proceeds of $250,000 and maximum gross proceeds of $1,000,000. According to the company, the net proceeds will be used for general working capital and business development.

The LIFE Offering is being made to purchasers resident in each of the provinces of Canada, other than Québec, pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106, as amended by Coordinated Blanket Order 45-935. This is subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 –Prospectus Exemptions (“NI 45-106”).

Securities offered under the LIFE Offering are expected to be immediately freely tradeable under applicable Canadian securities legislation if sold to purchasers’ resident in Canada. The Canadian Securities Exchange may impose a hold period in accordance with its policies in certain circumstances.

An offering document related to the LIFE Offering can be accessed under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.metasphere.earth. Prospective investors should read the Offering Document before making an investment decision.

The LIFE Offering is expected to close in one or more tranches, with the final closing expected to occur on or about April 24, 2026, or another date determined by the Company. Closing of the LIFE Offering is subject to customary conditions, including receipt of necessary corporate and regulatory approvals, including the approval of the CSE. The Company does not expect to pay any finder’s fees in connection with the LIFE Offering.

The securities referred to in this news release have not been and will not be registered under the U.S. Securities Act or any state securities laws. They may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.

This news release does not constitute an offer for sale of securities or a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the Company and management, as well as financial statements. “United States” and “U.S. person” have the respective meanings assigned in Regulation S under the U.S Securities Act.

Metasphere Labs Inc. specializes in integrating blockchain technology into real-world applications, with a focus on environmental sustainability and social impact.

Source: Metasphere Labs Inc.

LeadsAndCopy

Share this story:

TwitterFacebookLinkedInEmail
×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.